Vikas Sinha

See Remarks at Kalaris Therapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: Kalaris Therapeutics Inc., 3 years.

Kalaris Therapeutics Inc. Director ยท See Remarks
3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 19, 2024 Kalaris Therapeutics Inc. Open-market sale โˆ’3,159 $0.76 $2,401
May 17, 2024 Kalaris Therapeutics Inc. Open-market sale โˆ’3,143 $0.75 $2,357
May 3, 2024 Kalaris Therapeutics Inc. Open-market sale โˆ’4,957 $0.80 $3,966
Apr 22, 2024 Kalaris Therapeutics Inc. Open-market sale โˆ’1,857 $0.75 $1,393
Apr 19, 2024 Kalaris Therapeutics Inc. Open-market sale โˆ’1,521 $0.75 $1,141
Apr 2, 2024 Kalaris Therapeutics Inc. Open-market sale โˆ’885 $0.77 $681
Feb 20, 2024 Kalaris Therapeutics Inc. Open-market sale โˆ’2,893 $0.70 $2,025
Feb 5, 2024 Kalaris Therapeutics Inc. Open-market sale โˆ’18,331 $0.67 $12,282
Jan 23, 2024 Kalaris Therapeutics Inc. Open-market sale โˆ’3,205 $0.67 $2,147
Jan 4, 2024 Kalaris Therapeutics Inc. Open-market sale โˆ’961 $0.64 $615
Nov 17, 2023 Kalaris Therapeutics Inc. Open-market sale โˆ’2,490 $1.63 $4,059
Oct 20, 2023 Kalaris Therapeutics Inc. Open-market sale โˆ’1,475 $1.54 $2,272
Oct 19, 2023 Kalaris Therapeutics Inc. Open-market sale โˆ’1,232 $1.58 $1,947
Oct 3, 2023 Kalaris Therapeutics Inc. Open-market sale โˆ’755 $1.98 $1,495
Aug 17, 2023 Kalaris Therapeutics Inc. Open-market sale โˆ’10,516 $2.50 $26,290

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.